Aptus Pharma, a pharmaceutical company, has confirmed May 12, 2026, as the record date for its upcoming 3:2 bonus share issue. This move comes after the company's shares experienced a substantial 209% increase over the last six months, signaling robust market performance.
The board of Aptus Pharma finalized the record date to determine the eligibility of shareholders entitled to receive these bonus shares. The proposal for issuing bonus shares was previously approved by members via postal ballot through e-voting on April 25, 2026.
A Look at Aptus Pharma's Performance
The company's shares have shown impressive growth, gaining 138% year-to-date in 2026. Over a shorter period, the stock rose 18.31% in the past month and 59% in three months. Despite these significant gains, the stock closed on a flat note at Rs 408.50 on the day of the announcement, with a market capitalization of Rs 280.23 crore.
Technical indicators suggest the stock remains in a bullish zone. Aptus Pharma shares are trading above their 5-day, 10-day, 20-day, 30-day, 50-day, 100-day, 150-day, and 200-day moving averages, indicating a positive trend. However, the Relative Strength Index (RSI) stands at 75.7, suggesting the stock is currently in an overbought territory.
Company Profile
Incorporated in 2010, Aptus Pharma Ltd. specializes in the marketing and distribution of finished pharmaceutical formulations, contributing to its strong position in the market.